EP0730493A1 - Use of a polymer material based on modified hydrocolloids as encapsulating material - Google Patents
Use of a polymer material based on modified hydrocolloids as encapsulating materialInfo
- Publication number
- EP0730493A1 EP0730493A1 EP95922491A EP95922491A EP0730493A1 EP 0730493 A1 EP0730493 A1 EP 0730493A1 EP 95922491 A EP95922491 A EP 95922491A EP 95922491 A EP95922491 A EP 95922491A EP 0730493 A1 EP0730493 A1 EP 0730493A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- use according
- hydrocolloids
- radical
- compounds
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
- B01J13/206—Hardening; drying
Definitions
- the invention relates to the use of a polymer material based on modified hydrocolloids as the covering material.
- Critical working materials include understood dangerous, flammable, volatile, autoxidable, reactive, thermosensitive, polymerizable and / or toxic compounds which e.g. react prematurely with one another, contaminate the environment and / or harm humans and animals.
- legal requirements for handling critical materials provided that they include: fall under the regulations on hazardous substances, dangerous goods transport, the environment and occupational hygiene.
- Microencapsulation technology is an ideal packaging system for the temporary inerting of critical working materials.
- Microencapsulation is understood to mean the encapsulation of finely dispersed liquid and / or solid phases by coating them with film-forming polymers which, after emulsification and coacervation or surface polymerisation, are deposited on the material to be encased.
- the resulting microcapsules have protective covers and can be dried to a powder. In this way, a number of substances can be converted into a "dry mass”.
- the microcapsule content can then be released again if necessary by thermal, mechanical, chemical or enzymatic action, provided that there are still ingredients present.
- microcapsule wall materials known to date are diffusion-tight and therefore sufficiently stable for only a few specific capsule ingredients. This is also one of the reasons why that they use microencapsulation technologies only in a few product segments, such as for
- microcapsule walls had to be additionally equipped with secondary or tertiary walls in separate, expensive and time-consuming process steps. Such measures have often led to unsatisfactory results.
- DE-OS 2027737 describes a curable multicomponent adhesive or casting compound system in which mixtures which are practically manageable can be produced by means of complex cross-combinations of unsaturated polyester resins and poly-epoxy resins and their curing agents using microencapsulation technology. At least 4 reaction partners are necessary so that the protective cover walls are characterized by an inhomogeneous leak. As a result of the microcapsule walls being too strong, a high capsule destruction rate is not ensured under application conditions. Thus, this system could not prevail in commercial practice.
- SPARE BLADE (RULE 26) A large number of polymeric substances are proposed for the production of protective cover walls, the hydrocolloids taking a special position in addition to synthetic polymers.
- the type of capsule wall material used is largely determined by microencapsulation technology. This encapsulation technique can be in
- microencapsulation in organic solvents has continuously lost importance due to occupational safety (possibly fire and environmental hazards)
- microencapsulation in aqueous media has remained as a universal technology, provided that it is possible to work without dispersants.
- hydrocolloids and / or water-soluble synthetic polymers are required for the production of protective shell walls.
- wall materials include: gelatin, gum arabic, cellulose derivatives, polysaccharides, urea and / or melamine resins, polyurethane systems and the like.
- the substances to be encapsulated are water-insoluble but dispersible in water without damage. Furthermore, the substances to be encapsulated must be inert to the wall material medium.
- SPARE BLADE (RULE 26) Bringing together the dispersion and the solution and then triggering solvation and coacervation so that the colloidal wall material solution can wrap around the dispersed droplets of the substance to be encapsulated as a solvate shell.
- microcapsules After the microcapsules have been formed, they are separated from the aqueous medium and then washed, shrunk and, if appropriate, hardened and dried with suitable hardening agents.
- Aldehydes in particular glutaraldehydes, are preferably used as curing agents for hydrocolloids.
- microencapsulation technology can include U.S. 4,978,483; 2,712,507 and GB-A 751,600; 872 438; 927 157 and 949 910 as well as “Asaji Kondo” / J. Wade von Valkenburg, "Microcapsule Processing and Technology", Marcel Dekker Inc., New York - Basel, 1979.
- SPARE BLADE (RULE 26) Insignificance of microencapsulation technologies for packaging sensitive products and reaction systems and their use in various fields of application in the fields of technology, pharmacy and food.
- RULE 26 SPARE BLADE
- the object and aim of the present invention is to provide a shell material which is chemically and physically inert to the inner phase (capsule contents) and the outer phase, diffusion-tight, storage-stable, water- and / or solvent-resistant.
- hydrocolloids which are curable by polymerization and which are mono- or polysubstituted by ethylenically unsaturated radicals leads to a coating material with superior, advantageous properties.
- the invention thus relates to the use of a polymer material based on one or more modified hydrocoloids with a content of> 0.1% by mass (m%) of polymerizable or crosslinkable groups of the general formula
- R 1 represents a hydrogen atom, a hydroxyl, nitrile, halogen or C * -C 4 alkyl radical
- R 2 represents a saturated or unsaturated, at least divalent hydrocarbon radical, which if appropriate has one or more substituents selected from hydroxy, A ino-, C j -C 8 - alkyl, Cj-Cg alkoxy and / or hydroxy-C, -C 8 -alkyl group and which optionally has one or more hetero groups which are selected from - CO -,
- R 3 and R 4 which may be the same or different, represent a hydrogen atom, a hydroxyl group or a C j -C 4 alkyl radical and
- n 0 or 1; these groups are connected by a link to the backbone of the hydrocolloid, as a covering material for critical working materials.
- the polymer material is particularly useful as a diffusion-tight covering material for protecting the coated products from external influences and reactive components and for protecting the environment from the properties of the coated products.
- polymer material as a microcapsule wall material, as a coating material for drug forms or as a material for macrocapsules, in particular drug capsules, is particularly preferred.
- microcapsule wall material When used as a microcapsule wall material, in particular dangerous, toxic, flammable, autoxidable, volatile, thermosensitive and / or reactive agents and reaction systems can be packaged.
- polymerizable compounds polymerizable compounds; reactive compounds that harden according to the principle of polyaddition; hardening compounds; (reactive
- SPARE BLADE (RULE 26) ve) adhesives or sealants; Dowel compounds; sensory, fragrant and / or smelling substances; coloring substances, dyes or colors; Paints; Coatings; Casting compounds, blowing agents and foaming agents; autoxidationse pf indigenous substances etc. Pack stable and diffusion-tight.
- the protective cover walls in particular in liquid media, are diffusion-tight and that no diaphragm or membrane properties develop.
- This critical parameter of diffusion tightness is particularly important when, for example, even very small amounts of an ingredient can migrate through the protective cover wall due to migration and / or diffusion and can trigger unwanted reactions prematurely. As a result, a wide variety of undesirable moments of danger are preprogrammed and the product can no longer be used for its actual purpose.
- the term "diffusion-tight" includes u. a. the following.
- SPARE BLADE (RULE 26) A test method suitable for industrial practice has been developed for assessing and classifying the so-called diffusion tightness of a wall material according to the present invention.
- the microencapsulated substances are stored for a predetermined time unit "X" in a suitable, inert test medium, moved therein and / or heated if necessary.
- the test medium is preferably an inert organic solvent and / or water.
- Those wall materials that diffuse or migrate into the inert outer test medium phase during the predetermined time unit “X” vorplaceen 5.0, preferably ⁇ 3.0, in particular ⁇ 1.0 m% of one or more microcapsule ingredients are classified as diffusion-tight leave and give away.
- the diffused and / or migrated ingredients are then qualitatively and quantitatively analytical, e.g. determined by gas chromatography.
- the envelope material used according to the invention is based on functionalized hydrocolloids.
- the starting materials for their manufacture include known and conventional hydrocolloids or their basic raw materials.
- the chemical modification of the starting materials takes place by introducing side chains into the main molecular chains via reactive and / or functional groups without changing or damaging the colloid chemical and water-soluble properties.
- the shell materials can be prepared by conventional methods, e.g. using conventional microcapsule techniques, use and process.
- the hydrocolloids modified according to the invention have additional product parameters which already have a positive effect before, during and / or after coacervation, during curing and / or crosslinking. They therefore make an essential contribution to the construction and formation of inert, optionally waterproof and diffusion-tight envelope materials.
- the shell materials according to the invention are reactive, biodegradable hydrocolloids or backbone polymers. They result from an at least partial derivatization of the functional groups of the starting materials mentioned, for example hydroxyl, amino, imino, thiol and / or carboxyl groups, with a polymerizable radical of the general formula
- the radicals introduced into the main molecular chains of the hydrocolloids according to the present invention are ethylenically unsaturated radicals. These can be connected to the hydrocolloids directly or via the radical R 2 , for example a divalent, optionally substituted, aliphatic carbon, hydrogen or polyol radical.
- R 2 for example a divalent, optionally substituted, aliphatic carbon, hydrogen or polyol radical.
- the link between this residue and the polymer main chain accordingly results from the reaction of the functional groups of the hydrocolloid with the corresponding reactive groups of the polymerizable residue mentioned.
- the link is the same group as the hetero groups of the radical R 2 .
- hydrocoloid derivatives used according to the invention as envelope materials are water-soluble polymer materials which are functionalized by means of ethylenically unsaturated compounds according to the general formula above.
- the radical R 2 is at least one
- R 1 CH 2 C - X group, in which R 1 and X can have the above meaning and where several
- radicals R 1 or X can each be the same or different. Any hetero groups of the radical R 2 which are present can be arranged as bridging members to X or A both within the radical, in particular in the case of aliphatic radicals R 2 and / or at one or both ends of the radical R 2 .
- R 2 is an at least divalent optionally substituted glycol or polyol radical with 2-6 C atoms, the divalent radical of an oxy- or hydroxycarboxylic acid with 2-18 C atoms or the divalent radical one Carboxylic acid C 2 -C 6 glycol or C 6 -C 80 polyalkylene glycol ester.
- the radical R 2 is a C j -C 4 alkylene group which is optionally substituted by hydroxyl, amino and / or lower alkyl groups.
- R 2 can also have acyloxy, carbonyl, carbonyldioxy, carbamoyl, hydroximino, imino, ureylene and / or nitrilo bridge members (hetero groups).
- the ureylene bridge member is very particularly preferred.
- the functionalization of the hydrocolloids A with one or more reactive radicals takes place in particular via their Hydroxy1, amino, imino, thiol and / or carboxyl groups.
- the content of functional residues in the hydrocolloid A is ⁇ 0.1 m%. The particularly preferred contents are in the range from 1 to 50 m%, in particular 5 to 30 m%.
- the starting material for the water-soluble, biodegradable hydrocolloids or backbone polymers can come from the following polymer families:
- SPARE BLADE (RULE 26) - Proteins polypeptides, especially those of collagenous origin such as. e.g. B. Gelatin, animal glues, whey proteins, casein, vegetable proteins, especially soy proteins and the like. and their hydrolysates
- cellulose and its derivatives such as methyl cellulose, ethyl cellulose, hydroxy ethyl cellulose, carboxy ethyl cellulose, etc. , Starch and starch derivatives, glycogen, alginic acid and derivatives including salts, agar agar, heteropolysaccharides, heteroglycans, hemicelluloses and their derivatives, chitin, gum arabic and the like.
- the derivatization can take place by non-radical reaction or by grafting reactions on the backbone polymers.
- the functionalized backbone polymers or hydrocolloids in which the reactive groups have been introduced into the main molecular chains via a non-radical reaction. They contribute significantly to a homogeneous spectrum of properties, as has surprisingly been found.
- These functionalized products are produced by methods which are known to the person skilled in the art for the introduction of such side chains.
- the functional groups of the hydrocolloid can be reacted with a reactive derivative of the side chain residue or vice versa.
- SPARE BLADE suitable for functionalizing a large number of unsaturated compounds, in particular those containing acrylic, methacrylic and allyl groups, according to the above formula.
- Particularly preferred are such reactive groups which, inter alia, on Acrylklareglycidyle- ster, glycidyl methacrylate, Acryloxypropion- acid glycidyl ester, Methacryloxypropionchureglycidylester, Maleinklamonomethylacryloyloxiethylester, Diurethanmethacry- acrylate and allyl glycidyl carbonate, and (meth) acryla id are introduced into the hydrocolloid A.
- the polymerization required for curing can be carried out by homopolymerization of a hydrocolloid derivative containing the unsaturated radicals, but also by copolymerization of a mixture of such derivatives.
- the polymerization or copolymerization required for curing is carried out by adding or mixing in, by spraying, coating and / or in a bath with the reaction initiators required for systems of this type.
- inorganic per compounds such as e.g. Hydrogen peroxide, alkali and alkaline earth peroxides, persulfates, percarbonates
- organic peroxides such as Methyl ethyl ketone peroxides, cyclohexane peroxides, dibenzoyl peroxides, p-chlorobenzoyl peroxide, acetylacetone peroxide, cumene hydroperoxide and other initiators that trigger polymerizations.
- high-energy rays such as UV rays in the presence of a photoinitiator or electron beams can start the polymerization and copolymerization.
- accelerators are among others. based on heavy metal salts such as Cobalt acetylacetonate, vanadium naphthenate, tertiary amines such as e.g.
- the functionalized hydrocolloids according to the invention can be modified by further additives.
- Suitable additives include Plasticizers, dyes, pigments, inorganic and / or organic fillers and fibers. Stabilizers and / or inhibitors can also be added.
- mixtures of the hydrocolloids according to the invention with non-functionalized hydrocolloids can be particularly preferred if the coating materials have specific functions such as e.g. partial swellability in water have to be met, as has surprisingly been found.
- the shell materials in particular the microcapsule walls, must be more inert against specific chemical and / or environmental influences than can be achieved with the polymer crosslinking according to the invention.
- the remaining functional groups present in the hydrocolloid can be partially or completely reacted or rendered inert with other compounds which serve to harden or crosslink.
- These include Aldehydes, e.g.
- shrinking of the enveloping material, in particular the microcapsule walls may be necessary in individual cases. This shrinking takes place after the formation of the protective cover walls by means of known, conventional methods, such as e.g. with sodium sulfate solutions.
- the microcapsules are produced as stated at the beginning.
- the hardening or crosslinking of the protective cover walls can be carried out continuously and discontinuously.
- the microcapsules are placed in a bath in which the compounds used for curing or crosslinking are dissolved and / or dispersed.
- Water and / or organic solvents are suitable as solvents, water being preferred according to the invention.
- concentrations of these hardener solutions depend on the desired hardening time and temperature.
- accelerating compounds can be added to the hardener solution or can be carried out in a separate accelerator bath after the curing.
- the protective cover walls can also be hardened or crosslinked by spraying on the hardener and / or accelerator solutions.
- the microcapsule walls can also be hardened or crosslinked using high-energy rays.
- the hydrocolloids according to the invention are one or more photosensitive compounds, such as Benzoin and derivatives, benzil dimethyl ketals, 1-hydroxycyclohexyl phenyl ketones, benzophenones, 2,4,6-trimethylbenzoyldiphenyl phosphine oxides, alone or in combination with amine group-containing co-initiators, such as e.g. 2- (Dimethylamino) ethylbenzoate.
- No initiator additives are required for hardening or crosslinking with electron beams (ES). Radiation cans and
- the duration of exposure depends on the one hand on the contents of reactive groups in the hydrocolloids according to the invention and on the other hand on the microcapsule wall thicknesses and the contents.
- ERSArZBLATT (REGEL26) Substances dependent on the microcapsules.
- the exposure times are generally between 1 and 300 seconds for UV crosslinking with UV lamps with a power of 80 to 100 W / cm and for ES crosslinking between 5 and 70 kGy.
- Dual hardening or crosslinking means that other functional groups present in the hydrocolloids A, which can react according to other reaction mechanisms, during and / or separately from the free radical hardening or crosslinking with the suitable hardening or Networking connections are implemented.
- An example of this is the peroxidic curing or crosslinking and the reaction of -NH and / or OH groups of the hydrocolloids A with isocyanate groups in one or two separate steps.
- microcapsule wall materials according to the invention can be used to solve and simplify further tasks in enveloping and protecting gases and particles from liquids, pastes and dry substances.
- reproducible parameters can be developed and set because the hydrocolloids according to the invention have more homogeneous properties compared to the conventional microcapsule wall materials.
- the solutions of the microcapsule wall materials according to the invention can be added with the compounds used for curing or crosslinking.
- Particularly suitable for this are those per compounds and / or peroxides which only act as initiators at elevated temperatures and thus have sufficient pot lives.
- This has the advantage that the hardening or crosslinking can be initiated immediately after the protective shell walls have been formed. Hardening or crosslinking can be accelerated by spraying a solution of reaction accelerators onto the protective cover walls and / or introducing the microcapsules into an accelerator bath.
- the protective cover walls can also be hardened or crosslinked in hardening and / or accelerating baths, if appropriate tempered.
- the microcapsule wall materials according to the invention offer further advantages, as has surprisingly been found.
- a solution of the hydrocolloids according to the invention is introduced into liquid media with dispersed particles or droplets to be coated (stable dispersion)
- Gaussian distribution curve has smaller coefficients than the microcapsules produced with conventional hydrocolloids.
- the proportion of free coacervates is surprisingly low, which among other things reduce the washing times considerably.
- SPARE BLADE (RULE 26) Another essential feature is the possibility of a homogeneous hardening or crosslinking and the formation of bridge members (crosslinking) in order to arrive at a more stable capsule wall matrix.
- crosslinking By hardening or crosslinking, the hydrocolloids according to the invention become their sol / gel
- the present invention solves further essential tasks in the dehydration and drying of protective cover walls. While a number of very critical, changing parameters are present in the dehydration and drying of protective casings made from conventional hydrocolloids, which can optionally be hardened with aldehydes according to the prior art, these do not occur when using the wall materials according to the invention. In the case of conventional protective wall materials, these critical parameters include based on the fact that it
- SPARE BLADE (RULE 26) have too long dehydration and drying times - often several days - at relatively low temperatures, even when using modern drying techniques.
- the protective cover walls consist of the hydrocolloids according to the present invention
- the above and other disadvantages can not only be eliminated, but they also offer further advantages as homogeneously hardened or crosslinked gels, as has surprisingly been found.
- One of these advantages according to the invention is that the dehydration and drying of the hardened or crosslinked protective shell gels can be accomplished in a fraction of the time as with conventional hydrocolloids with increasing temperatures, depending on the thermosensitivity of the encapsulated ingredients. It is particularly preferred for dehydration and drying according to the present invention to use conditioned drying air which has a relative air humidity ⁇ 50%, in particular ⁇ 40%, and drying air temperatures between 20 ° C. and 100 ° C.
- the protective cover gels according to the invention dehydrate and dry
- the hardened or cross-linked protective gel gels according to the present invention only require a fraction of drying aids such as e.g. expensive pyrogenic silica compared to conventional processes.
- the polymer material is also suitable for coating drug forms, in particular coated tablets, capsules and tablets.
- the polymer material can be chosen so that an enteric coating or an enteric coating results.
- the polymer material can also be used in the form of macrocapsules for coating the above-mentioned products.
- Pharmaceutical capsules are particularly worth mentioning here.
- a gelatin-based polymer material is then preferably used. Both full capsules and push-fit capsules can be produced.
- the capsules are produced in the usual way.
- microencapsulation technology is not only given new impulses for the more economical production of protective sleeves with functionally reliable membrane properties and. improved storage stability, but also created the conditions to use them industrially and commercially.
- storage-stable, waterproof and, if necessary, diffusion-tight packaging systems such as the microcapsules create the prerequisites for the temporary inerting of dangerous, toxic, flammable, autoxidable, volatile, i.e. evaporating or sublimating, thermally sensitive and / or reactive working materials and systems.
- the simultaneously simplified process technology also ensures a high level of economy.
- Wall material A derivatized gelatin (according to the invention) Gelatin strength according to Bloom: 272 g viscosity according to Bloom / 50 ° C 50 mPa.s
- Wall material B unmodified gelatin (comparison) gelatin strength according to Bloom: 272 g viscosity according to Bloom / 50 ° C: 50 mPa.s
- Wall material A was allowed to swell in cold water and the mixture was then heated to about 45 ° C. without stirring. This temperature of 45 ° C was maintained. After the wall material A had dissolved, 0.5 kg of sodium polyphosphate and 0.3 kg of sodium acetate were added with the agitator running and mixed in homogeneously.
- the pH was adjusted to about 5 by adding a 5% sodium hydroxide solution and a 50% glutaraldehyde solution for pre-curing the finished wall was added. This pre-curing with the glutaraldehyde solution took about 24 hours.
- a 50% glutaraldehyde solution for further hardening or crosslinking of the functional parts.
- About 0.250 kg of sodium peroxodisulfate (Na 2 S 2 0 8 ) were added to the batch of methacrylic groups of wall material A and homogeneously dissolved and distributed by stirring. To accelerate this reaction, 0.250 liters of 50% triethanolamine were added. After a stirring time of about 8 hours, this hardening was complete.
- microcapsules formed were then allowed to sediment and washed 3 times with fresh water.
- a drying aid e.g. pyrogenic silica, mixed in and the microcapsule suspension was filtered.
- the wet microcapsule cake obtained (60-70% water content) was then dried in a fluidized bed dryer with increasing drying air temperature from 18 ° C to 40 ° C and a relative humidity ⁇ 40%. The drying time was 18 hours.
- the microcapsules obtained were in the form of individual capsules and were free-flowing.
- Example 1 was repeated in such a way that a 15 kg bisphenol A dimethacrylate / triethylolpropane trimethacrylate mixture (1: 1) was encapsulated instead of the benzoyl peroxide paste.
- the other process conditions corresponded to Example 1.
- the drying time was 17 hours.
- Example 1 was repeated in such a way that instead of
- Wall material A the wall material B was used.
- Example 2 was repeated in such a way that instead of
- This example differs from the above in that the hardening or crosslinking of the methacrylic groups in the wall material A is initiated with the onset of coacervation.
- Example 2 was repeated in such a way that 0.250 kg of sodium peroxodisulfate were dissolved in the residual water amount of 10 liters before the start of coacervation and then added to the batch.
- the hardening or crosslinking of the wall material A was also initiated. Since free radical curing or crosslinking takes place more slowly in the acidic area, no stresses build up in the wall material and it is hardened more homogeneously and more stably. Glutaraldehyde curing was not carried out. Otherwise, the procedure was as in Example 1.
- O ⁇ i peroxidic ingredients have the wall material according to the invention "self-healing" effects by post-curing.
- An oxidation-sensitive coffee aroma was microencapsulated with this wall material using the method described in Example 1. Glutaraldehyde precuring and free-radical crosslinking with sodium peroxodisulfate were dispensed with. At the end of the drying process, the wall material was hardened with electron beams and a radiation dose of 20 kGy. - In parallel, films with a wall thickness of 15 ⁇ m were produced in an analogous manner on a glass plate from the wall material in order to be able to determine the oxygen permeability of the wall material. The oxygen permeation (ASTM) was 25 ml / d / m 2 / bar at 25 ° C / 0% relative air humidity. The gelatin wall had tough elastic properties. The microencapsulated coffee aroma was checked again after 3 months of storage in daylight. The coffee aroma showed no changes in an organoleptic test that could be attributed to auto-oxidation.
- microencapsulation was carried out according to Example 1.
- microcapsule walls were absolutely tight after 6 months of toluene storage.
- a "self-healing" effect on mechanically damaged microcapsule walls was also possible to be watched. This is probably due to the -NH groups from the acrylamide, which have reacted with the epoxy groups of the epoxy resin.
- a thin-boiling corn starch with a content of 1.4 mmol / g of glycidyl methacrylate was selected for coating tablets (coated tablets).
- the shell material had the following composition:
- Iron oxides 83.00 parts by weight of distilled water
- the wall material was suspended in the cold distilled water and the suspension was then heated in a beaker and briefly boiled.
- the color pigment was dispersed into the starch solution obtained on cooling.
- the coating material solution was then processed using an airless, multi-component spray gun.
- the hardener solution consisting of a 10% potassium peroxodisulfate solution in water was simultaneously fed to the multi-component nozzle.
- the mixing ratio was 10: 1 (starch solution to hardener). Spraying was carried out at 60 ° C.
- the spraying process was ended after 30 minutes and the coated tablets were subsequently dried with a warm air stream (80 ° C.), with the acrylic-modified starch being cured at the same time.
- the tablets showed a homogeneous, red coating layer, which was also stable against mechanical loads.
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4419724A DE4419724A1 (en) | 1994-06-06 | 1994-06-06 | Storage-stable and diffusion-proof microcapsule wall material |
DE4419724 | 1994-06-06 | ||
PCT/EP1995/002107 WO1995033554A1 (en) | 1994-06-06 | 1995-06-02 | Use of a polymer material based on modified hydrocolloids as encapsulating material |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0730493A1 true EP0730493A1 (en) | 1996-09-11 |
EP0730493B1 EP0730493B1 (en) | 2000-08-30 |
Family
ID=6519899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95922491A Expired - Lifetime EP0730493B1 (en) | 1994-06-06 | 1995-06-02 | Use of a polymer material based on modified hydrocolloids as encapsulating material |
Country Status (12)
Country | Link |
---|---|
US (1) | US5690869C1 (en) |
EP (1) | EP0730493B1 (en) |
JP (1) | JP3503138B2 (en) |
KR (1) | KR960703667A (en) |
AT (1) | ATE195890T1 (en) |
CA (1) | CA2162280C (en) |
DE (2) | DE4419724A1 (en) |
DK (1) | DK0730493T3 (en) |
ES (1) | ES2151961T3 (en) |
PT (1) | PT730493E (en) |
TW (1) | TW284777B (en) |
WO (1) | WO1995033554A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10427722B2 (en) | 2006-12-22 | 2019-10-01 | Sika Technology Ag | Reinforcing system for reinforcing a cavity of a structural element |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4135995B2 (en) * | 1997-07-15 | 2008-08-20 | ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス | Cross-linked plant protein particles, in particular microparticles or nanoparticles, preparation method and cosmetic, pharmaceutical or food composition comprising the same |
FR2766090B1 (en) * | 1997-07-15 | 1999-10-08 | Coletica | PARTICLES, IN PARTICULAR MICRO- OR NANOPARTICLES OF CROSS-LINKED VEGETAL PROTEINS, THEIR PREPARATION PROCESS AND COSMETIC, PHARMACEUTICAL OR FOOD COMPOSITIONS, CONTAINING |
DE19735460A1 (en) * | 1997-08-16 | 1999-02-18 | Rolf Prof Dr Med Zander | Rinsing or storage fluid for blood cells |
US6780507B2 (en) | 2000-02-09 | 2004-08-24 | Analytical Research Systems, Inc. | Hydrocapsules and method of preparation thereof |
JP4759157B2 (en) * | 2001-03-30 | 2011-08-31 | 新田ゼラチン株式会社 | Crosslinking agent for gelatin |
GB2375340B (en) * | 2001-05-10 | 2003-09-10 | Croda Int Plc | Gelatin substitute |
AU2002246950A1 (en) * | 2002-01-08 | 2003-07-30 | Analytical Research Systems | Hydrocapsules and method of preparation |
EP1371410A1 (en) * | 2002-06-14 | 2003-12-17 | NIZO food research | Complex coacervates containing whey proteins |
EP2018948A1 (en) | 2007-07-27 | 2009-01-28 | Sika Technology AG | Method for manufacturing a sandwich element |
CN101952361A (en) * | 2007-07-31 | 2011-01-19 | 亮志国际有限公司 | A composition and uses thereof |
DE202011109958U1 (en) | 2011-11-23 | 2012-08-30 | GESI Gewindesicherungs-GmbH | thread Locking |
DE202011109949U1 (en) | 2011-11-23 | 2012-08-13 | GESI Gewindesicherungs-GmbH | thread coating |
EP3554801A1 (en) | 2016-12-14 | 2019-10-23 | Sika Technology AG | Instant pre-fixation of adhesive bonded insert parts which is preferably made of plastic with the help of chemical screws |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2608456B1 (en) * | 1986-12-18 | 1993-06-18 | Mero Rousselot Satia | MICROCAPSULES BASED ON GELATIN AND POLYSACCHARIDES AND PROCESS FOR OBTAINING THEM |
AU634606B2 (en) * | 1989-11-06 | 1993-02-25 | Alkermes Controlled Therapeutics, Inc. | Method for producing protein microspheres |
US4941284A (en) * | 1989-12-15 | 1990-07-17 | David Stoller | Parking space barrier |
AU666895B2 (en) * | 1991-12-30 | 1996-02-29 | Hercules Incorporated | High load spray dry encapsulation |
DE4210334A1 (en) * | 1992-03-30 | 1993-10-07 | Stoess & Co Gelatine | Biodegradable, water-resistant polymer material |
-
1994
- 1994-06-06 DE DE4419724A patent/DE4419724A1/en not_active Withdrawn
-
1995
- 1995-06-02 KR KR1019960700622A patent/KR960703667A/en not_active Application Discontinuation
- 1995-06-02 ES ES95922491T patent/ES2151961T3/en not_active Expired - Lifetime
- 1995-06-02 DE DE59508683T patent/DE59508683D1/en not_active Expired - Lifetime
- 1995-06-02 DK DK95922491T patent/DK0730493T3/en active
- 1995-06-02 CA CA002162280A patent/CA2162280C/en not_active Expired - Lifetime
- 1995-06-02 AT AT95922491T patent/ATE195890T1/en active
- 1995-06-02 WO PCT/EP1995/002107 patent/WO1995033554A1/en active IP Right Grant
- 1995-06-02 EP EP95922491A patent/EP0730493B1/en not_active Expired - Lifetime
- 1995-06-02 PT PT95922491T patent/PT730493E/en unknown
- 1995-06-02 JP JP50034896A patent/JP3503138B2/en not_active Expired - Lifetime
- 1995-06-06 TW TW084105701A patent/TW284777B/zh not_active IP Right Cessation
- 1995-10-05 US US08537665 patent/US5690869C1/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
See references of WO9533554A1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10427722B2 (en) | 2006-12-22 | 2019-10-01 | Sika Technology Ag | Reinforcing system for reinforcing a cavity of a structural element |
Also Published As
Publication number | Publication date |
---|---|
ATE195890T1 (en) | 2000-09-15 |
CA2162280C (en) | 2005-04-05 |
ES2151961T3 (en) | 2001-01-16 |
DE4419724A1 (en) | 1995-12-07 |
WO1995033554A1 (en) | 1995-12-14 |
US5690869A (en) | 1997-11-25 |
EP0730493B1 (en) | 2000-08-30 |
JPH09501734A (en) | 1997-02-18 |
TW284777B (en) | 1996-09-01 |
PT730493E (en) | 2000-12-29 |
KR960703667A (en) | 1996-08-31 |
DE59508683D1 (en) | 2000-10-05 |
JP3503138B2 (en) | 2004-03-02 |
DK0730493T3 (en) | 2000-09-18 |
CA2162280A1 (en) | 1995-12-07 |
US5690869C1 (en) | 2001-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0038985B1 (en) | Microcapsules having a specific opening temperature, method for their preparation and their application | |
EP0730493A1 (en) | Use of a polymer material based on modified hydrocolloids as encapsulating material | |
DE1500856C3 (en) | Method for applying a layer with a liquid-containing microcapsules to a connecting element | |
DE3037309C2 (en) | ||
DE2818102C2 (en) | ||
DE2658221A1 (en) | METHOD OF ENCAPSULATING BIOLOGICALLY ACTIVE SUBSTANCES | |
DE2820600A1 (en) | METHOD FOR THE PRODUCTION OF MICROCAPSULA COATING COMPOSITIONS WITH PIGMENT ARTICLES AND COMPOSITIONS PRODUCED THEREOF | |
DE1444415A1 (en) | Method for encapsulating substances | |
DD207150A5 (en) | METHOD OF OVERRUPTING MEDICINAL PRODUCTS BY MEANS OF A WATER-DISPERSED CONSUMPTION AGENT | |
CH664906A5 (en) | METHOD FOR PRODUCING A SLUDGE OF MICROCAPSULES. | |
DE2010115A1 (en) | Process for the production of micro-granules | |
DE1817316B2 (en) | Process for the production of microcapsules with liquid capsule contents and reinforced capsule walls | |
DE1769194B2 (en) | Coating agent for the formation of an opaque coating | |
DE1150482B (en) | Paints for plastic containers | |
DE2135721A1 (en) | Water-resistant, microcapsule-like, highly impermeable system | |
WO2011051033A2 (en) | Encapsulation of reactive components for 1-k systems using coaxial dies | |
DE2010110A1 (en) | Process for the production of microcapsules with the aid of synthetic coacervates | |
EP0602513B1 (en) | Powder Composition containing microcapsules with a core useable as a levelling agent | |
DE1151784B (en) | Process for the production of very small capsules that can be broken by heat | |
DE2206806A1 (en) | Weatherable substrate coated with a coating resin | |
DE19754342A1 (en) | Microencapsulated rubber additive | |
DE2109940A1 (en) | Anti dirt, water and atmospheric corrosion coating | |
DE2015672C3 (en) | Process for the production of plates and foils for chromatography, in particular for thin-layer chromatography, and adsorbents for carrying out the process | |
AT366592B (en) | METHOD FOR PRODUCING A BASIC COACERVATE AS A BASIC MATERIAL FOR MICRO-ENCLOSURE | |
DE1542262A1 (en) | Process for the production of capsules filled with liquid or solid materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960304 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19980527 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000830 |
|
REF | Corresponds to: |
Ref document number: 195890 Country of ref document: AT Date of ref document: 20000915 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: PATENTANWALTSBUERO JEAN HUNZIKER |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: GERMAN |
|
ET | Fr: translation filed | ||
REF | Corresponds to: |
Ref document number: 59508683 Country of ref document: DE Date of ref document: 20001005 |
|
ITF | It: translation for a ep patent filed |
Owner name: MARCHI & PARTNERS S.R.L. |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20001128 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20000901 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2151961 Country of ref document: ES Kind code of ref document: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010602 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010602 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010630 |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: HUG INTERLIZENZ AG |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20140610 Year of fee payment: 20 Ref country code: GB Payment date: 20140528 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20140602 Year of fee payment: 20 Ref country code: AT Payment date: 20140528 Year of fee payment: 20 Ref country code: CH Payment date: 20140612 Year of fee payment: 20 Ref country code: IT Payment date: 20140620 Year of fee payment: 20 Ref country code: ES Payment date: 20140513 Year of fee payment: 20 Ref country code: SE Payment date: 20140611 Year of fee payment: 20 Ref country code: DE Payment date: 20140630 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20140611 Year of fee payment: 20 Ref country code: NL Payment date: 20140610 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20140609 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 59508683 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20150602 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V4 Effective date: 20150602 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20150601 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK07 Ref document number: 195890 Country of ref document: AT Kind code of ref document: T Effective date: 20150602 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MK9A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20150609 Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20150601 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20150925 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20150602 Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20150603 |